BD plans to hire 187 in NC; Harvard to tighten gift rules;

> Gov. Bev Perdue today announced that BD (Becton, Dickinson and Company) will invest $38.4 million to build a warehouse and East Coast distribution center in Johnston County, NC. The company plans to hire 187 workers to staff the facility over three years beginning in 2012. The project was made possible in part by a $600,000 grant from the One North Carolina Fund. Release

> Harvard Medical School will prohibit its 11,000 faculty from giving promotional talks for drug and medical device makers and accepting personal gifts, travel, or meals, under a new policy intended partly to guard against companies' use of Harvard's prestige to market their products. Report

> The National Institute for Health and Clinical Excellence has issued its first draft guidance under its new medical technologies programme, recommending the drug-coated balloon catheter SeQuent Please for in-stent restenosis. Story

> Women who fail to become pregnant after undergoing in vitro fertilization treatment often grapple with the decision of whether to try IVF again. Now a team of Stanford University School of Medicine researchers has developed a model to predict the outcomes of a subsequent round of IVF for those women who have already gone through a cycle. Release

> BIOLASE Technology, has announced the appointment of two veterans of business, finance and medicine to its board of directors. Alex Arrow and Norman J. Nemoy will join the board effective immediately, replacing George V. d'Arbeloff and Robert M. Anderton, who have resigned their positions effective immediately. Release

> William Kokoszka has filed a personal injury lawsuit against Zimmer, the nation's largest producer of orthopedic devices. Following his 2006 hip replacement, Kokoszka suffered constant and devastating pain for over 18 months before having to undergo a second hip replacement surgery due to an allegedly defective hip implant manufactured and sold by Zimmer under the brand name Durom Cup. Release

> The treatment of diabetes was revolutionized in 1922 when insulin was isolated from dogs. Now, human medicine has returned the favor and used these advances to help dogs with diabetes. A University of Missouri researcher is using a continuous glucose monitoring device--commonly used in humans with diabetes--to help treat dogs and other animals.  Release

And Finally... The most interesting logos in biopharma. Report

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.